Rinri Therapeutics

United Kingdom
Sheffield, England, United Kingdom, S1 4DP

Company profile

Rinri Therapeutics company profile

Rinri Therapeutics is a provider of private biotechnology services intended to develop advanced regenerative stem cell-based therapies for the treatment of hearing loss. The company's stem cell technology replaces damaged or dead sensory cells of the inner ear, enabling doctors to restore hearing of patients.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Postal code
S1 4DP
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$13.8M
Last funding
Grant / $4.5M / 2021-05-13
Last equity funding
Series Unknown / $12M
Investors
5
Lead investors
3
Founders
1
Articles
26

Founders and investors

Founders

Marcelo Rivolta

Lead investors

Boehringer Ingelheim Venture FundInnovate UKUCB Ventures

Investors

BioCity GroupBoehringer Ingelheim Venture FundInnovate UKThe Future FundUCB Ventures